SlideShare une entreprise Scribd logo
1  sur  19
[object Object],[object Object]
5th European Conference on Rare Diseases   ECRD, Krakow Proposal for a Directive on Patients’ rights in cross-border healthcare OPENING THE DOOR TO BETTER  HEALTHCARE ACROSS EUROPE 15 May 2010 Andrzej RYS  Director European Commission, DG SANCO  Directorate C -  Public Health and Risk Assessment
The 3 Aims of this initiative   ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
2. Ensuring Safer & Better Quality  cross-border healthcare by c larifying responsibilities ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Safeguards to ensure fair and equitable system for  health authorities ,[object Object],[object Object],[object Object],[object Object],[object Object]
3.  Fostering cooperation between healthcare systems to improve  healthcare for all ,[object Object],[object Object],[object Object],[object Object]
European Reference Networks - ERN (Article 13) ,[object Object],[object Object],[object Object],[object Object]
European Reference Networks - ERN ,[object Object],[object Object]
European Reference Networks - ERN ,[object Object],[object Object],[object Object],[object Object],[object Object]
European Reference Networks - ERN ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
European Reference Networks - ERN ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Situation of the political process ,[object Object],[object Object],[object Object],[object Object]
The position of the EP ,[object Object],[object Object],[object Object]
The Commission position on the latest SE compromise text ,[object Object],[object Object],[object Object],[object Object]
The Swedish Presidency ,[object Object],[object Object],[object Object]
The Spanish Presidency ,[object Object],[object Object],[object Object],[object Object]
Possible Next Steps ,[object Object],[object Object],[object Object],[object Object]
[object Object]

Contenu connexe

Tendances

Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries" Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries" EURORDIS - Rare Diseases Europe
 
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"EURORDIS - Rare Diseases Europe
 
Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"EURORDIS - Rare Diseases Europe
 
Kathi Apostolidis on Cross Border Healthcare Directive
Kathi Apostolidis on Cross Border Healthcare DirectiveKathi Apostolidis on Cross Border Healthcare Directive
Kathi Apostolidis on Cross Border Healthcare DirectivefrancescoECPC
 
Norwegian Romanian (No Ro) Parternership For Progress In
Norwegian Romanian (No Ro) Parternership For Progress InNorwegian Romanian (No Ro) Parternership For Progress In
Norwegian Romanian (No Ro) Parternership For Progress InMihaiela Fazacas
 
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...Canadian Organization for Rare Disorders
 
Existing resources, funding opportunities at EU and national levels
Existing resources, funding opportunities at EU and national levelsExisting resources, funding opportunities at EU and national levels
Existing resources, funding opportunities at EU and national levelsEURORDIS Rare Diseases Europe
 
Rare Disease Day: Discussion of a good practice example: Mavris
Rare Disease Day: Discussion of a good practice example: MavrisRare Disease Day: Discussion of a good practice example: Mavris
Rare Disease Day: Discussion of a good practice example: MavrisNowgen
 
The Challenges of Cross-Border Healthcare Law
The Challenges of Cross-Border Healthcare LawThe Challenges of Cross-Border Healthcare Law
The Challenges of Cross-Border Healthcare LawKathi Apostolidis
 

Tendances (20)

Session 2 terkel_andersen
Session 2 terkel_andersenSession 2 terkel_andersen
Session 2 terkel_andersen
 
Sesion 2 terkel 14 05 2010 (final)
Sesion 2 terkel 14 05 2010 (final)Sesion 2 terkel 14 05 2010 (final)
Sesion 2 terkel 14 05 2010 (final)
 
Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries" Workshop 3 - "Feedback from the 15 National Conferences on Registries"
Workshop 3 - "Feedback from the 15 National Conferences on Registries"
 
Workshop 4 - "EURORDIS Research Policy recommendation"
Workshop 4 - "EURORDIS Research Policy recommendation"Workshop 4 - "EURORDIS Research Policy recommendation"
Workshop 4 - "EURORDIS Research Policy recommendation"
 
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
 
Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"Workshop 6 - "Training package on RD for medical students"
Workshop 6 - "Training package on RD for medical students"
 
Destitute Roma & access to healthcare
Destitute Roma & access to healthcareDestitute Roma & access to healthcare
Destitute Roma & access to healthcare
 
Session 2 segolene_ayme
Session 2 segolene_aymeSession 2 segolene_ayme
Session 2 segolene_ayme
 
Kathi Apostolidis on Cross Border Healthcare Directive
Kathi Apostolidis on Cross Border Healthcare DirectiveKathi Apostolidis on Cross Border Healthcare Directive
Kathi Apostolidis on Cross Border Healthcare Directive
 
Session 3 yann_le_cam
Session 3 yann_le_camSession 3 yann_le_cam
Session 3 yann_le_cam
 
Session 3 fons_gabreels
Session 3 fons_gabreelsSession 3 fons_gabreels
Session 3 fons_gabreels
 
Norwegian Romanian (No Ro) Parternership For Progress In
Norwegian Romanian (No Ro) Parternership For Progress InNorwegian Romanian (No Ro) Parternership For Progress In
Norwegian Romanian (No Ro) Parternership For Progress In
 
Workshop 5 - "The Norwegian Model"
Workshop 5 - "The Norwegian Model" Workshop 5 - "The Norwegian Model"
Workshop 5 - "The Norwegian Model"
 
Julio E. Celis-Investigar, educar, dialogar
Julio E. Celis-Investigar, educar, dialogarJulio E. Celis-Investigar, educar, dialogar
Julio E. Celis-Investigar, educar, dialogar
 
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
Daria Julkowska, E-Rare Net, Transforming Rare Disease Research through Trans...
 
Existing resources, funding opportunities at EU and national levels
Existing resources, funding opportunities at EU and national levelsExisting resources, funding opportunities at EU and national levels
Existing resources, funding opportunities at EU and national levels
 
Rare Disease Day: Discussion of a good practice example: Mavris
Rare Disease Day: Discussion of a good practice example: MavrisRare Disease Day: Discussion of a good practice example: Mavris
Rare Disease Day: Discussion of a good practice example: Mavris
 
The Challenges of Cross-Border Healthcare Law
The Challenges of Cross-Border Healthcare LawThe Challenges of Cross-Border Healthcare Law
The Challenges of Cross-Border Healthcare Law
 
A partnership with the academic world
A partnership with the academic world A partnership with the academic world
A partnership with the academic world
 

Similaire à Session 25 andrzej_rys

European Union Action in the field of Rare Diseases
European Union Action in the field of Rare DiseasesEuropean Union Action in the field of Rare Diseases
European Union Action in the field of Rare DiseasesPlan de Calidad para el SNS
 
Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009Mihaiela Fazacas
 
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe" Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe" EURORDIS - Rare Diseases Europe
 
Catherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCatherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCittadinanzattiva onlus
 
1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, Introduction1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, IntroductionCornelia Adlhoch
 
European guidelines mammography
European guidelines mammographyEuropean guidelines mammography
European guidelines mammographyZoran Mirkov
 
literature PP pd obat kanker.pdf
literature PP pd obat kanker.pdfliterature PP pd obat kanker.pdf
literature PP pd obat kanker.pdfMarlinaAzwar1
 
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvisTue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvis3GDR
 
EPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de LooEPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de LooMarc van Gurp
 
Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"
Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"
Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"EURORDIS - Rare Diseases Europe
 
Joint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceJoint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceDutch Orphan Drug Network
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI
 
Current regulations regarding eHealth in Europe by Frank Lievens
Current regulations regarding eHealth in Europe by Frank LievensCurrent regulations regarding eHealth in Europe by Frank Lievens
Current regulations regarding eHealth in Europe by Frank LievensApollo Hospitals Group and ATNF
 

Similaire à Session 25 andrzej_rys (20)

European Union Action in the field of Rare Diseases
European Union Action in the field of Rare DiseasesEuropean Union Action in the field of Rare Diseases
European Union Action in the field of Rare Diseases
 
Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009Montsserat Rtd Presentation Cluj 2009
Montsserat Rtd Presentation Cluj 2009
 
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe" Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
 
Session 25 antoni_montserrat
Session 25 antoni_montserratSession 25 antoni_montserrat
Session 25 antoni_montserrat
 
Antoni Montserrat
Antoni MontserratAntoni Montserrat
Antoni Montserrat
 
Sesion 2 segolene ayme eu krakow may 10
Sesion 2 segolene ayme eu krakow may 10Sesion 2 segolene ayme eu krakow may 10
Sesion 2 segolene ayme eu krakow may 10
 
Catherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCatherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD Coalition
 
1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, Introduction1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, Introduction
 
European guidelines mammography
European guidelines mammographyEuropean guidelines mammography
European guidelines mammography
 
CBA on reference laboratories human pathogens
CBA on reference laboratories human pathogensCBA on reference laboratories human pathogens
CBA on reference laboratories human pathogens
 
literature PP pd obat kanker.pdf
literature PP pd obat kanker.pdfliterature PP pd obat kanker.pdf
literature PP pd obat kanker.pdf
 
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvisTue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
 
EPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de LooEPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de Loo
 
Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"
Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"
Workshop 2- "Feedback from the 15 National Conferences on Centres of Expertise"
 
Joint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task ForceJoint Rare Diseases / Orphan Medicinal Products Task Force
Joint Rare Diseases / Orphan Medicinal Products Task Force
 
Update: National Plans for Rare Diseases
Update: National Plans for Rare Diseases Update: National Plans for Rare Diseases
Update: National Plans for Rare Diseases
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
 
Current regulations regarding eHealth in Europe by Frank Lievens
Current regulations regarding eHealth in Europe by Frank LievensCurrent regulations regarding eHealth in Europe by Frank Lievens
Current regulations regarding eHealth in Europe by Frank Lievens
 
Jornadas #PatientInHTA · Iñaki Imaz
Jornadas #PatientInHTA · Iñaki ImazJornadas #PatientInHTA · Iñaki Imaz
Jornadas #PatientInHTA · Iñaki Imaz
 
eHealth in Europe: Rules and Regulations
eHealth in Europe: Rules and RegulationseHealth in Europe: Rules and Regulations
eHealth in Europe: Rules and Regulations
 

Plus de EURORDIS - Rare Diseases Europe

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...EURORDIS - Rare Diseases Europe
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseEURORDIS - Rare Diseases Europe
 
Update on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgUpdate on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgEURORDIS - Rare Diseases Europe
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyEURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...EURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...EURORDIS - Rare Diseases Europe
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...EURORDIS - Rare Diseases Europe
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"EURORDIS - Rare Diseases Europe
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"EURORDIS - Rare Diseases Europe
 

Plus de EURORDIS - Rare Diseases Europe (18)

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...
 
RareConnect.org Update 2016
RareConnect.org Update 2016RareConnect.org Update 2016
RareConnect.org Update 2016
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare disease
 
Living with TRAPS poll results
Living with TRAPS poll resultsLiving with TRAPS poll results
Living with TRAPS poll results
 
Pitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.orgPitt Hopkins syndrome community on RareConnect.org
Pitt Hopkins syndrome community on RareConnect.org
 
The Value of Online Communities
The Value of Online CommunitiesThe Value of Online Communities
The Value of Online Communities
 
Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014
 
Update on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgUpdate on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.org
 
Surveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org ExperienceSurveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org Experience
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients Globally
 
Rare disease day 2011 highlights
Rare disease day 2011 highlightsRare disease day 2011 highlights
Rare disease day 2011 highlights
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...
 
Conference 3 "Outcomes of 15 National Conferences, "
Conference 3   "Outcomes of 15 National Conferences, "Conference 3   "Outcomes of 15 National Conferences, "
Conference 3 "Outcomes of 15 National Conferences, "
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop on registries"
 

Dernier

Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 

Dernier (20)

Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 

Session 25 andrzej_rys

  • 1.
  • 2. 5th European Conference on Rare Diseases ECRD, Krakow Proposal for a Directive on Patients’ rights in cross-border healthcare OPENING THE DOOR TO BETTER HEALTHCARE ACROSS EUROPE 15 May 2010 Andrzej RYS Director European Commission, DG SANCO Directorate C - Public Health and Risk Assessment
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.

Notes de l'éditeur

  1. NON HOSPITAL CARE The rule is NO PRIOR AUTHORISATION for reimbursement of healthcare if it is reimbursed by the MS of affiliation. So, the patient has the right to seek healthcare in another MS without PA & to be reimbursed (eg. consultations) This is identical in latest SW text HOSPITAL CARE INITIAL PROPOSAL: MS may choose to introduce a system of PA for reimbursement IF the outflow of patients risks undermining financial balance or planning of the hospital sector LATEST TEXT: PA system CAN be introduced (NO CONDITIONS except necessary, non discriminatory and proportionate) Intro an OPEN list of REASONS for REFUSING to grant a PA CLEAR RULES ON REIMBURSEMENT Upfront payment with reimbursement at home up to the level for the same or similar treatment in the home system INFORMATION AVAILABLE TO PATIENTS to make informed decisions to provide patients with equal opportunities to receive cross-border healthcare PROCEDURAL GUARANTEES fair & quick procedures right to ask for a review of administrative decision
  2. Clarifies that MS of treatment is overall responsible Applies to all healthcare private and public
  3. Efficient use of resources: Strengthening eHealth and improving interoperability European Reference networks (to share expertise and innovation on specialised care) Sharing efforts on Health Technology Assessment Easier recognition of prescriptions issued in other MS Information on cross-border flows – for planning (not anymore there)
  4. FYI: “ The Commission shall support Member States in the development of European reference networks between healthcare providers and centres of expertise in the Member States. The networks shall be based on voluntary participation by its members, which shall participate and contribute to the networks activities according to the legislation of the Member State where they are established”. “ Providing clarity on the definition of an ERN” through: - developing & publishing criteria & conditions that the ERN should fulfil in order to receive support from the Commission - developing & publishing criteria for evaluating ERN;
  5. FYI: “ The Commission shall support Member States in the development of European reference networks between healthcare providers and centres of expertise in the Member States. The networks shall be based on voluntary participation by its members, which shall participate and contribute to the networks activities according to the legislation of the Member State where they are established”. “ Providing clarity on the definition of an ERN” through: - developing & publishing criteria & conditions that the ERN should fulfil in order to receive support from the Commission - developing & publishing criteria for evaluating ERN;
  6. FYI: “ The Commission shall support Member States in the development of European reference networks between healthcare providers and centres of expertise in the Member States. The networks shall be based on voluntary participation by its members, which shall participate and contribute to the networks activities according to the legislation of the Member State where they are established”. “ Providing clarity on the definition of an ERN” through: - developing & publishing criteria & conditions that the ERN should fulfil in order to receive support from the Commission - developing & publishing criteria for evaluating ERN;
  7. FYI: “ The Commission shall support Member States in the development of European reference networks between healthcare providers and centres of expertise in the Member States. The networks shall be based on voluntary participation by its members, which shall participate and contribute to the networks activities according to the legislation of the Member State where they are established”. “ Providing clarity on the definition of an ERN” through: - developing & publishing criteria & conditions that the ERN should fulfil in order to receive support from the Commission - developing & publishing criteria for evaluating ERN;
  8. FYI: “ The Commission shall support Member States in the development of European reference networks between healthcare providers and centres of expertise in the Member States. The networks shall be based on voluntary participation by its members, which shall participate and contribute to the networks activities according to the legislation of the Member State where they are established”. “ Providing clarity on the definition of an ERN” through: - developing & publishing criteria & conditions that the ERN should fulfil in order to receive support from the Commission - developing & publishing criteria for evaluating ERN;
  9. The latest Swedish Compromise text (26/11/09) - Main provisions : NON-HOSPITAL CARE: no PA may be introduced HOSPITAL CARE SW text weakened the proposal Regarding PA in the latest SW text: EC ok to dilution of its proposal only to enable 1st reading For hospital care & highly-specialised care , MS may introduce a PA system in so far as it is justified, non discriminatory and proportionate to the objective pursued (financial stability of the system). MAIN PROBLEMS The OPEN list of reasons for refusing an individual prior authorisation. It allows MS to refuse for any reasons not listed Refusal for "undue delay“ introduced in SW (same wording for refusing under 883/2004: confusing & no progress for patients!!)
  10. New Spanish Proposal: Basis: Swedish text Only 4 points of discussion: Dual legal basis MS of affiliation-pensioners quality of care eHealth